FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

The FDA approved a supplemental ANDA for Triamterene and Hydrochlorothiazide from Zydus Pharmaceuticals (USA) Inc., enabling the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hypertension

Drugs mentioned

• Triamterene and Hydrochlorothiazide (generic) (Triamterene and Hydrochlorothiazide)

Snippet

SUPPL AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)